FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

13755911000001105: Ambrisentan 10mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
48994901000001111 Ambrisentan 10mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
48995001000001111 Ambrisentan 10mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

6 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ambrisentan 10mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets 30 tablet Is pack of Product containing precisely ambrisentan 10 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets 30 tablet Has active ingredient Ambrisentan false Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets 30 tablet Has VMP Product containing precisely ambrisentan 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets 30 tablet Has specific active ingredient Ambrisentan true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ambrisentan 10mg tablets (Cipla EU Ltd) 30 tablet Is a True Ambrisentan 10mg tablets 30 tablet Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Viatris UK Healthcare Ltd) 30 tablet 2 x 15 tablets Is a True Ambrisentan 10mg tablets 30 tablet Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Accord Healthcare Ltd) 30 tablet 3 x 10 tablets Is a True Ambrisentan 10mg tablets 30 tablet Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Dr Reddy's Laboratories (UK) Ltd) 30 tablet 3 x 10 tablets Is a True Ambrisentan 10mg tablets 30 tablet Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Zentiva Pharma UK Ltd) 30 tablet Is a True Ambrisentan 10mg tablets 30 tablet Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) 30 tablet 3 x 10 tablets Is a True Ambrisentan 10mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start